Nov 12 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS REPORTS FINANCIAL AND OPERATIONAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2022 AND CHANGE OF CHIEF FINANCIAL OFFICER
* APPILI THERAPEUTICS INC - KENNETH G. HOWLING WILL BE JOINING APPILI THERAPEUTICS AS ACTING CHIEF FINANCIAL OFFICER THIS FALL
* APPILI THERAPEUTICS INC - KIMBERLY STEPHENS, CO'S CFO HAS CHOSEN TO LEAVE APPILI FOR PERSONAL REASONS EFFECTIVE NOVEMBER 16, 2021
Source text for Eikon: ID:nBw9xg5Ksa Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))